| For: | Gong SS, Fan YH, Han QQ, Lv B, Xu Y. Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease. World J Gastroenterol 2019; 25(18): 2240-2250 [PMID: 31143074 DOI: 10.3748/wjg.v25.i18.2240] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i18/2240.htm |
| Number | Citing Articles |
| 1 |
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese, Laurent Peyrin-Biroulet. A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. Journal of Crohn's and Colitis 2021; 15(1) doi: 10.1093/ecco-jcc/jjaa093
|
| 2 |
Ryan Njeim, Elie Moussa, Chapman Wei, Joelle Sleiman, Reem Dimachkie, Liliane Deeb. Impact of Biologics and Proton Pump Inhibitors on Gastrointestinal Infection Risk in Inflammatory Bowel Disease Patients: A Retrospective Analysis of Pathogen-Specific Outcomes and Treatment Interactions. Biomedicines 2025; 13(7) doi: 10.3390/biomedicines13071676
|
| 3 |
Alaa El-Hussuna, Almuthe Christina Hauer, Tarkan Karakan, Valerie Pittet, Henit Yanai, Jalpa Devi, Jesus K Yamamoto-Furusho, Ali Reza Sima, Hailemichael Desalegn, Mutaz Idrees Sultan, Vishal Sharma, Hany Shehab, Lamya Mrabti, Natalia Queiroz, Anuraag Jena, Andy Darma, Karin Davidson, Nicolas Avellaneda, Muhammed Elhadi, April Roslani, Dakshitha Wickramasinghe, Carlo Angelo Cajucom, Shaji Sebastian. ECCO consensus on management of inflammatory bowel disease in low- and middle-income countries. Journal of Crohn’s and Colitis 2026; 20(1) doi: 10.1093/ecco-jcc/jjaf125
|
| 4 |
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?. International Immunopharmacology 2023; 116 doi: 10.1016/j.intimp.2022.109597
|
| 5 |
Scott D. Lee, Jessica R. Allegretti, Flavio Steinwurz, Susan B. Connelly, Nervin Lawendy, Jerome Paulissen, Krisztina B. Gecse. Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-022-02508-2
|
| 6 |
Antonio Pizuorno Machado, Abdullah Salim Shaikh, Alice Saji, Malek Shatila, Isabella Glitza Oliva, Yinghong Wang, Anusha Shirwaikar Thomas. Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer. Cancers 2024; 16(10) doi: 10.3390/cancers16101919
|
| 7 |
Rios Ricci José Eugenio, Tarsila Campanha da Rocha Ribeiro, Fernando Antonio Basile Colugnati, Lívia de Almeida Costa, Pedro de Morais, Jordana AS Lopes, Hugo B Araújo, Matheus A Pacheco, Mariana V de S Paulo, João Baptista de Paula Fraga, Lucélia Paula Cabral Schmidt, Thais de Andrade Almeida, Roberta Oliveira Raimundo Borsato, Liliana Andrade Chebli, Júlio Maria Fonseca Chebli. Incidence and treatment-based risk stratification of opportunistic infections in patients with inflammatory bowel disease: an ambispective cohort study in Brazil. Intestinal Research 2026; doi: 10.5217/ir.2025.00208
|
| 8 |
Anders Forss, Jordan Axelrad, Jonas Söderling, Karl Mårild, Hans Strid, Jonas Halfvarson, Caroline Nordenvall, Charlotte Hedin, Martin Rejler, Olof Grip, Ulrika L. Fagerberg, Karl Mårild, Johann Hreinsson, Ola Olén, Olof Grip, Johann P. Hreinsson, Jonas Halfvarson, Pontus Naucler, Jonas F. Ludvigsson, Ola Olén. Serious Infections in Patients With Inflammatory Bowel Disease and Corticosteroids: A Propensity Score–Matched Study. Clinical Gastroenterology and Hepatology 2026; doi: 10.1016/j.cgh.2026.08.019
|
| 9 |
Alyssa K. Mezochow, Douglas E. Schaubel, Eliot G. Peyster, James D. Lewis, David S. Goldberg, Therese Bittermann. Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries. Transplant Infectious Disease 2024; 26(4) doi: 10.1111/tid.14317
|
| 10 |
S. A. Tsvetikova, E. E. Kruglov, L. G. Danilov, D. S. Zilov, Yu. V. Myakisheva, M. A. Makarova, L. A. Kaftyreva, E. I. Koshel. Composition and Pathogenic Potential of Mucosal Microbiota in Ulcerative Colitis. Russian Journal of Bioorganic Chemistry 2024; 50(2) doi: 10.1134/S1068162024110463
|
| 11 |
Anand Kumar, Tatiana Teslova, Erin Taub, Joshua D. Miller, Dana J. Lukin. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications. Digestive Diseases and Sciences 2021; 66(6) doi: 10.1007/s10620-020-06439-4
|
| 12 |
Robbe Winters, Sara Kaut, Dries Govaerts, Aaron De Poortere, Ilse Mombaerts, Ilse Hoffman, Robin Willaert, Karen van Hoeve. Myositis of pterygoid muscles and superior ophthalmic vein and cavernous sinus thrombosis in active Crohn’s disease undergoing ustekinumab treatment: a case report and literature review. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1544466
|
| 13 |
Sangwoo Han, Serena R. Martin, Robert V. Bryant. Inflammatory Bowel Disease Nursing Manual. 2025; doi: 10.1007/978-3-031-87503-8_24
|
| 14 |
Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis. World Journal of Pediatrics 2022; 18(1) doi: 10.1007/s12519-021-00486-1
|
| 15 |
Jennie Clough, Michael Colwill, Andrew Poullis, Richard Pollok, Kamal Patel, Sailish Honap. Biomarkers in inflammatory bowel disease: a practical guide. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241251600
|
| 16 |
Koji Yokoyama, Masahiko Sakabe, Mitsukazu Mamada. A Case of Refractory Kawasaki Disease With Yersinia pseudotuberculosis Infection Successfully Treated With Cefotaxime Following Immunosuppressive Therapy. Cureus 2024; doi: 10.7759/cureus.73866
|
| 17 |
Trusha Patel, Andrew B. Grossman. Updates in Healthcare Maintenance and Monitoring of Children with Inflammatory Bowel Disease in the Era of Biologic Therapies. Current Treatment Options in Pediatrics 2019; 5(4) doi: 10.1007/s40746-019-00181-4
|
| 18 |
Luigi Marongiu, Sascha Venturelli, Heike Allgayer. Involvement of HHV-4 (Epstein–Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-Analysis. Cancers 2022; 14(20) doi: 10.3390/cancers14205085
|
| 19 |
Predicting Severe Infection Risk in Autoimmune Rheumatic Disease by Assessing the Impact of Immune Factors and Immunosuppressive Therapy. Indian Journal of Rheumatology 2026; doi: 10.1177/09733698261433332
|
| 20 |
Zi-Ning Zhang, Li-Xuan Sang. Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it. World Journal of Gastroenterology 2024; 30(36): 4025-4030 doi: 10.3748/wjg.v30.i36.4025
|
| 21 |
Vincenzo Craviotto, Federica Furfaro, Laura Loy, Alessandra Zilli, Laurent Peyrin-Biroulet, Gionata Fiorino, Silvio Danese, Mariangela Allocca. Viral infections in inflammatory bowel disease: Tips and tricks for correct management. World Journal of Gastroenterology 2021; 27(27): 4276-4297 doi: 10.3748/wjg.v27.i27.4276
|
| 22 |
Cátia Arieira, Francisca Dias de Castro, Tiago Cúrdia Gonçalves, Maria J. Moreira, José Cotter. Combination therapy in inflammatory bowel disease patients: do we need to maximize the dose of azathioprine?. Scandinavian Journal of Gastroenterology 2020; 55(8) doi: 10.1080/00365521.2020.1792543
|
| 23 |
Maede Ghanaeipour, Nima Behnaminia, Erfan Khadem, Amirhossein Nafari. The Risk of Opportunistic Infections in Patients with Inflammatory
Bowel Disease. The International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666220124111511
|
| 24 |
Estera Banasik, Agnieszka Dobrowolska, Lucyna Woźnicka-Leśkiewicz, Piotr Eder. Diagnostic Challenges of Cyclosporiasis in Chronic Diarrhea: A Case Study. Microorganisms 2025; 13(9) doi: 10.3390/microorganisms13092209
|
| 25 |
Kathryn Gazelakis, Isabel Chu, Catherine Martin, Miles P. Sparrow. Infections in inflammatory bowel disease patients on immunomodulator and biologic therapy are not associated with high serum drug levels. Internal Medicine Journal 2024; 54(1) doi: 10.1111/imj.16105
|